Searching for keyword:"Metabolic syndrome"

1,288 results
Record publications over time
Ironsift results are limited for unregistered users. Register or log in to see all records.

US Clinical Trial NCT00307411 – NIH – Mar 27, 2006

Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-Aged Men With Metabolic Syndrome

Metabolic syndrome, a constellation of glucose intolerance, hypertension, dyslipidemia, obesity, pro-inflammatory and prothrombotic state culminating to development of premature cardiovascular diseases is a serious public health problem with signifi...
Full record

US Clinical Trial NCT00452192 – NIH – Mar 26, 2007

Detailed Analysis of the Effects of Telmisartan on Renal Perfusion in Patients With Metabolic Syndrome

see above
Full record

US Clinical Trial NCT00189085 – NIH – Sep 12, 2005

The Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Dysfunction in Patients With the Metabolic Syndrome.

In patients at high risk for future cardiovascular events, more intensive LDL cholesterol lowering with high doses statin therapy provides greater protection against death or major cardiovascular events than does a standard regimen. Intensive LDL ch...
Full record

US Clinical Trial NCT00296803 – NIH – Feb 23, 2006

PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT00138528 – NIH – Aug 25, 2005

Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT01367431 – NIH – Mar 15, 2011

Xanthohumol and Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT01182844 – NIH – Aug 13, 2010

Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota

Obesity and metabolic disorders (type 2 diabetes and insulin resistance) are tightly linked to inflammation. Obesity, a pandemic affecting 30-50% of the adult population, is mediated by a variety of genetic and environmental factors. It is well desc...
Full record

US Clinical Trial NCT01741298 – NIH – Nov 27, 2012

Biobehavioral Bases & Management of Metabolic Syndrome

The metabolic syndrome is increasingly being recognized as a major threat to good health - especially cardiovascular health - and its frequency appears to be increasing in relation to the current epidemic of obesity. The objective of this study is t...
Full record

US Clinical Trial NCT00395486 – NIH – Nov 1, 2006

A 6-week, Randomised, Open-label, Parallel Group, Multi-centre Study to Compare the Efficacy of Rosuvastatin 10mg With Atorvastatin 10mg in the Treatment of Metabolic Syndrome Subjects With Raised LDL-C

No preview available.
Full record

US Clinical Trial NCT01770054 – NIH – Jan 15, 2013

Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents...
Full record

US Clinical Trial NCT00534183 – NIH – Sep 21, 2007

Metabolic Profile and Anthropometric Changes in Schizophrenia

we aimed to study the effects of antipsychotics, olanzapine, risperidone and haloperidol on development of metabolic syndrome in a drug naïve population suffering from first episode schizophrenia and compared it with a matched healthy control group....
Full record
Register to view full records and receive email notifications.

US Clinical Trial NCT00569764 – NIH – Dec 6, 2007

The Effects of Metabolic Parameters of Aripiprazole in Patients With Schizophrenia

To measure the long-term changes in weight, plasma lipids and fasting blood glucose after switching antipsychotic treatment to aripiprazole, 1 year, open label studies in out and in-patients with schizophrenia. The measurement of weight and lipid p...
Full record

US Clinical Trial NCT01931527 – NIH – Aug 23, 2013

Effect of Plasma Uric Acid on Insulin Sensitivity, Endothelial Function and Inflammation

It has been hypothesized that oxidative stress is involved in the pathogenesis of insulin resistance associated with obesity. Circulating uric acid (UA) is the body's major endogenous plasma antioxidant. Therefore, the investigators evaluated whethe...
Full record

US Clinical Trial NCT00543985 – NIH – Oct 11, 2007

Exercise in Patients With Metabolic Syndrome and Weight Regain - Echocardiography Substudy

Patients must have 2 of the 5 criteria for metabolic syndrome and be able to exercise in a monitored setting for 45 min 5 times a week.
Full record

US Clinical Trial NCT00171548 – NIH – Sep 12, 2005

Project to Promote the Evaluation of Cardiovascular Risk in Clinical Practice, and Assess Its Evolution After the Implementation of Multifactorial Preventive Strategy Aimed at Reducing the Level of Global Risk (SCORE Algorithm) in Subjects With Metabolic Syndrome and a Risk Level of 5%

No preview available.
Full record

US Clinical Trial NCT01293162 – NIH – Feb 9, 2011

Study on the Role of a Combination of Nutraceuticals (Armolipid Prev) With an Effect on Blood Pressure and Lipids in the Control of Cardiovascular Risk

Study on the role of a combination of nutraceuticals (Armolipid Prev) with an effect on blood pressure and lipids in the control of cardiovascular risk. APv - cpr - 0210 1. Study rationale The strategies for the prevention of cardiovascular diseas...
Full record

US Clinical Trial NCT00300365 – NIH – Mar 6, 2006

A Randomized, Double Blind, Placebo Controlled Trial of Pioglitazone and Niacin Extended Release in Non-diabetic Patients With Metabolic Syndrome

This is a two-arm, parallel, double-blind randomized prospective clinical trial. The subjects will be asked to provide informed consent, and then undergo screening for enrollment criteria at the first visit (-5 weeks). The subjects who are eligible,...
Full record

US Clinical Trial NCT00605436 – NIH – Jan 16, 2008

Restorative Yoga for Therapy of the Metabolic Syndrome: A Pilot Trial

Study Interventions: There will be a 12-week intervention period. 1. Yoga Therapy Group: Those randomized to yoga therapy will receive twice-weekly group yoga sessions at the Osher Center for the entire intervention period. The yoga postures and br...
Full record

US Clinical Trial NCT01785615 – NIH – Feb 1, 2013

Interactions of Thrombogenic, Lipogenic, and Inflammatory Markers in Women With the Metabolic Syndrome - Effect of Atorvastatin

The first phase of the study is an observational phase as previously described. The second phase was a prospective evaluation of the effect of a well known "statin" drug (Lipitor) on different biochemical factors measured in the blood. The eligible...
Full record

US Clinical Trial NCT03708549 – NIH – Oct 13, 2018

Comparison of the Efficacy and Safety of Berberine and Metformin for Schizophrenia Patients With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT03445741 – NIH – Feb 11, 2018

Effects of Different Intensities and Durations of Aerobic Exercise Training and Detraining on Metabolic, Hormonal Responses and Abdominal Obesity in Women With Metabolic Syndrome.

Objective: To show metabolic and hormonal responses and effects on abdominal obesity of aerobic exercise in different intensity and duration and detraining period in women with metabolic syndrome. Methods: Fifty-one women with metabolic syndrome we...
Full record
Register to view full records and use our APIs.

US Clinical Trial NCT01176630 – NIH – Aug 4, 2010

Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population

Risk factors for metabolic syndrome will be collected for each consented patient. They include elevated serum triglycerides, reduced HDL cholesterol, hypertension, elevated fasting blood sugar concentration and abdominal obesity. The investigator wi...
Full record

US Clinical Trial NCT00666848 – NIH – Apr 23, 2008

Effect of Sitagliptin on the Blood Pressure Response to ACE Inhibition in the Metabolic Syndrome

The prevalence of metabolic syndrome and Type 2 diabetes mellitus (T2DM) has reached epidemic proportions in developed countries and is closely associated with hypertension. As new oral hypoglycemic agents become available for clinical use, practiti...
Full record

US Clinical Trial NCT01705678 – NIH – Apr 12, 2012

An Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease in Males With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT01410851 – NIH – Jul 27, 2011

The Acute Effects of Pulse Consumption on Glycaemic Responses and Measures of Satiety and Satiation

No preview available.
Full record

US Clinical Trial NCT02069717 – NIH – Feb 18, 2014

Multi-center, Prospective, Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) Add-on to Statin Therapy in Patients Who Have History of Acute Myocardial Infarction and Are Diagnosed With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT02219906 – NIH – Aug 14, 2014

Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation

Patients with metabolic syndrome are at increased risk of thrombotic complications, including myocardial infarction and cardiovascular death. A meta-analysis of the studies assessing cardiovascular risk in metabolic syndrome found a pooled relative...
Full record

US Clinical Trial NCT01944579 – NIH – Sep 12, 2013

No preview available.
Full record

US Clinical Trial NCT02050607 – NIH – Nov 7, 2013

Fecal Microbiota Transplantation for the Treatment of Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT02034435 – NIH – Jan 9, 2014

Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

In aim 1 subjects are randomized to cross over between an 8 day high salt and 8 day low salt diet and assessments are made. In aim 2, subjects are randomized to a 2x2 cross over study with an 8 day low salt diet and either eplerenone 50mg or amlodi...
Full record

US Clinical Trial NCT02298621 – NIH – Nov 5, 2014

The Effect of Pomegranate Juice Intake on Cardiometabolic Factors in Subjects With Metabolic Syndrome.

The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic syndrome in shabestar.
Full record
Register to view full records and advanced analytics.

US Clinical Trial NCT01278628 – NIH – Jan 18, 2011

No preview available.
Full record

US Clinical Trial NCT02455778 – NIH – May 25, 2015

Effect of Intervention With Oral Cinnamon on Metabolic Profile and Body Composition of Asian Indians With Metabolic Syndrome in North India: A 16 Week Double Blind Placebo Control Trial

No preview available.
Full record

US Clinical Trial NCT03139214 – NIH – Apr 28, 2017

Parenting Intervention and Metabolic Syndrome

In this study, the investigators conducted a parenting intervention (Strong African American Families, or SAAF). Families (mothers with their 11 year old child) were randomized to either the parenting intervention or to a control group. Those in the...
Full record

US Clinical Trial NCT02885935 – NIH – Aug 24, 2016

The investigators investigated changes in insulin sensitivity before and after 4 weeks of dietary intervention and control in subjects with metabolic syndrome. Two groups of subjects were studied before and after a weight maintenance diet. Group 1 w...
Full record

US Clinical Trial NCT02918448 – NIH – Sep 21, 2016

A Resistance Training Program Decreases the Risk of Metabolic Syndrome and Inflammatory Biomarkers in Older Adult Women: A Randomized Controlled Trial

The aim of this study was to investigate the effects of a 12-week resistance training (RT) program on body composition, risk factors for metabolic syndrome (MetS), and inflammatory biomarkers in older adult women. For the selection of the sample all...
Full record

US Clinical Trial NCT02670382 – NIH – Dec 23, 2015

Role of EPA and DHA in Fish Oil on Inflammation and Lipoprotein Metabolism

This is a randomized, placebo-controlled, double-blind, crossover study of the effects of EPA and DHA on inflammation and lipid metabolism in 24 men and women with metabolic syndrome. The study will characterize the effects of EPA alone and DHA alon...
Full record

US Clinical Trial NCT03058016 – NIH – Feb 7, 2017

Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study

Pre-diabetic and pre-metabolic syndrome patients will be recruited to the study for a period of one year. After measurement of individual's parameters changes as blood tests, gut microbiome, urine tests, blood pressure, heart performance, body circ...
Full record

US Clinical Trial NCT03977064 – NIH – Jun 4, 2019

Fertility and Cardiovascular Risk in Men With Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT03504735 – NIH – Mar 15, 2018

Effect of Caduet and TLC Intervention on Metabolic Parameters

Single center, investigator driven, double blinded, randomized with Caduet 5/10mg vs placebo. The participants visited with investigators on a monthly bases to evaluate the BP, weight, and obtain the waist measurements, and counseling. OGTT was perf...
Full record

US Clinical Trial NCT03355469 – NIH – Nov 7, 2017

Exercise Dose and Metformin for Vascular Health in Adults With Metabolic Syndrome

No preview available.
Full record
Register to view full records and disable ads.

US Clinical Trial NCT03300271 – NIH – Sep 24, 2017

Effects of a Supportive Mobile Health for Life Style Modification on Blood Pressure and Insulin Resistance Improvement in People With Metabolic Abnormalities

The purpose of this randomized study is to assess the efficacy of a mobile application for the improvement of blood pressure and insulin resistance in people with metabolic syndrome. This study is a 24 week follow up randomized prevention trial. Pa...
Full record

US Clinical Trial NCT02746887 – NIH – Dec 9, 2015

Risk Factors Related to Metabolic Syndrome in School-aged Children Who Were Born Preterm

No preview available.
Full record

US Clinical Trial NCT02610322 – NIH – Nov 18, 2015

A Randomized Controlled Trial of Whole Soy Diet in Place of Red/Processed Meat and High Fat Dairy Products on Metabolic Features in Postmenopausal Women

No preview available.
Full record

US Clinical Trial NCT03265184 – NIH – Aug 25, 2017

Effects of Green Coffee Extract Supplementation on Oxidative Stress, Systemic and Vascular Inflammation in Patients With Metabolic Syndrome: A Randomized Clinical Trial

No preview available.
Full record

US Clinical Trial NCT03214068 – NIH – Jul 6, 2017

Evaluation of the Pattern of Thyroid Dysfunctions in Patients With Metabolic Syndrome

The metabolic syndrome (MetS) is a clustering of multiple risk factors for atherosclerotic cardiovascular disease such as central obesity, impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM), elevated triglyceride (TG), reduced high de...
Full record

US Clinical Trial NCT00748787 – NIH – Sep 8, 2008

Multicenter, Double Blind, Randomized, Controlled With Placebo, to Evaluate the Effect of the Treatment With Plantago Ovata Husk in the Incidence of the Remission of Metabolic Syndrome in Children and Adolescents Between 10 to 16 Years Old.

The prevalence of the metabolic syndrome is increasing in the last decade as well in adult people as in children and adolescents. The early diagnosis and treatment measures could be very important in order to reduce the cardiovascular risk in such p...
Full record

US Clinical Trial NCT01755104 – NIH – Dec 18, 2012

A Randomized Double-blind Placebo Controlled Trial on the Effect of Stablor™ on the Abdominal Visceral Fat Mass Loss in Patients With a Metabolic Syndrome

No preview available.
Full record

US Clinical Trial NCT02008838 – NIH – Dec 8, 2013

No preview available.
Full record

US Clinical Trial NCT01668888 – NIH – Aug 14, 2012

No preview available.
Full record